PortfoliosLab logo

Arbutus Biopharma Corporation (ABUS)

Equity · Currency in USD · Last updated Dec 7, 2022

Company Info

ISINCA03879J1003
CUSIP03879J100
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$2.43
Year Range$1.88 - $4.38
EMA (50)$2.41
EMA (200)$2.62
Average Volume$919.36K
Market Capitalization$394.30M

ABUSShare Price Chart


Loading data...

ABUSPerformance

The chart shows the growth of $10,000 invested in Arbutus Biopharma Corporation in Nov 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $3,480 for a total return of roughly -65.20%. All prices are adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%JulyAugustSeptemberOctoberNovemberDecember
-7.55%
-1.91%
ABUS (Arbutus Biopharma Corporation)
Benchmark (^GSPC)

ABUSCompare to other instruments

Search for stocks, ETFs, and funds to compare with ABUS

ABUSReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-3.92%4.53%
6M-4.30%-4.37%
YTD-37.02%-17.31%
1Y-40.96%-13.16%
5Y-13.66%8.45%
10Y-7.28%10.78%

ABUSMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-27.76%13.88%-6.88%-21.81%4.29%11.52%-14.76%-3.90%-13.96%22.51%0.43%4.26%
20216.48%-0.79%-11.20%4.20%-18.44%7.07%-11.22%27.51%25.07%-6.06%-20.60%21.56%
2020-6.12%11.88%-65.41%14.85%87.07%-16.13%109.34%-23.62%7.56%-9.90%60.64%-21.63%
2019-3.66%18.97%-18.45%-24.86%-32.34%14.29%-14.42%-23.03%11.31%-6.89%17.61%66.47%
20180.99%6.86%-8.26%14.00%2.63%24.79%52.05%-18.02%3.85%-55.13%2.83%-12.16%
20178.16%0.94%21.50%4.62%-0.00%5.88%-4.17%21.74%47.62%-8.87%-0.00%-10.62%
2016-29.44%0.64%30.70%19.85%-16.36%-15.94%17.53%-6.85%-9.71%-8.43%-15.87%-7.55%
201569.04%-29.05%-3.91%-11.40%-9.70%-15.10%-8.68%-34.35%-14.35%-9.69%1.45%-20.25%
201475.16%47.92%4.07%-38.16%-4.44%2.83%-1.91%67.06%-1.21%-21.10%-8.99%-0.20%
2013-5.24%-5.95%6.55%1.27%4.82%-6.00%16.17%-0.55%27.99%28.78%-8.94%-2.21%
201238.67%23.08%1.56%-7.00%-11.12%-1.82%66.35%-4.84%8.68%11.29%23.51%-0.60%
201125.96%-16.39%-36.36%-4.44%10.63%-24.62%-3.98%-20.75%-5.76%-5.56%0.00%-11.76%
2010-27.98%-7.30%

ABUSSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Arbutus Biopharma Corporation Sharpe ratio is -0.53. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.200.00JulyAugustSeptemberOctoberNovemberDecember
-0.53
-0.59
ABUS (Arbutus Biopharma Corporation)
Benchmark (^GSPC)

ABUSDividend History


Arbutus Biopharma Corporation doesn't pay dividends

ABUSDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember
-92.08%
-17.83%
ABUS (Arbutus Biopharma Corporation)
Benchmark (^GSPC)

ABUSWorst Drawdowns

The table below shows the maximum drawdowns of the Arbutus Biopharma Corporation. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Arbutus Biopharma Corporation is 97.19%, recorded on Oct 9, 2019. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.19%Mar 12, 20141406Oct 9, 2019
-80.95%Jan 20, 2011213Nov 25, 2011457Sep 26, 2013670
-36.08%Nov 16, 201024Dec 20, 201020Jan 19, 201144
-31.5%Oct 8, 201346Dec 11, 201321Jan 13, 201467
-18.01%Feb 26, 20144Mar 3, 20142Mar 5, 20146
-9.03%Sep 27, 20132Sep 30, 20133Oct 3, 20135
-7.7%Jan 21, 20145Jan 27, 20143Jan 30, 20148
-6.4%Feb 21, 20141Feb 21, 20141Feb 24, 20142
-6.09%Feb 5, 20142Feb 6, 20143Feb 11, 20145
-5.73%Jan 14, 20141Jan 14, 20142Jan 16, 20143

ABUSVolatility Chart

Current Arbutus Biopharma Corporation volatility is 59.81%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


10.00%20.00%30.00%40.00%50.00%60.00%70.00%JulyAugustSeptemberOctoberNovemberDecember
59.81%
23.28%
ABUS (Arbutus Biopharma Corporation)
Benchmark (^GSPC)